While studies are currently exploring the possibilities of preventing these side effects, there are currently no GLP-1 drugs on the market that do not have the potential to cause these side effects
Nanoliposome-encapsulated and non-encapsulated phenolics from Achillea millefolium and their biological function in mice challenged by Campylobacter jejuni : a comparative study
doi: 10.2337/db11-1556 237 GalloMFLopezLMGrimesDACarayonFSchulzKFHelmerhorstFM
For meaningful assessment of treatment response, standardized measurements should be employed, including limb circumference at defined anatomical points, validated pain scales, and quality-of-life instruments specific to lipedema or lymphatic conditions
Currently, the PROTECT-ME study (ACTRN12617001515381), a triple-blind, randomized, parallel group, placebo-controlled trial, is trying to determine whether antenatal maternal melatonin supplementation improves neurodevelopmental outcomes at 2 years of age in children affected by FGR
Trajectory of weight regain after cessation of GLP-1 receptor agonists: A systematic review and nonlinear meta-regression